These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32028387)

  • 21. Procalcitonin levels predicting the infliximab response of immunoglobulin resistant Kawasaki disease.
    Nakashima Y; Nanishi E; Yamamura K; Uike K; Terashi E; Hirata Y; Nagata H; Morihana E; Tanaka T; Honjo S; Takada H; Ohga S
    Cytokine; 2019 Feb; 114():26-31. PubMed ID: 30583086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic significance of microRNAs in sepsis.
    Zheng X; Zhang Y; Lin S; Li Y; Hua Y; Zhou K
    PLoS One; 2023; 18(2):e0279726. PubMed ID: 36812225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio with retinal vein occlusion: a systematic review and meta-analysis.
    Liu Z; Perry LA; Penny-Dimri JC; Raveendran D; Hu ML; Arslan J; Britten-Jones AC; O'Hare F; Ayton LN; Edwards TL
    Acta Ophthalmol; 2022 May; 100(3):e635-e647. PubMed ID: 34219390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
    Sato S; Kawashima H; Kashiwagi Y; Hoshika A
    Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Higher efficacy of infliximab than immunoglobulin on Kawasaki disease, a meta-analysis.
    Li X; Tang Y; Ding Y; Chen Y; Hou M; Sun L; Qian G; Qin L; Lv H
    Eur J Pharmacol; 2021 May; 899():173985. PubMed ID: 33652059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease.
    Ye Q; Gong FQ; Shang SQ; Hu J
    Clin Immunol; 2016 Oct; 171():25-31. PubMed ID: 27519954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarkers of intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Kong WX; Ma FY; Fu SL; Wang W; Xie CH; Zhang YY; Gong FQ
    World J Pediatr; 2019 Apr; 15(2):168-175. PubMed ID: 30809758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Formosa score and diagnostic sensitivity and specificity of four Asian risk scores for predicting intravenous immunoglobulin resistance in Kawasaki disease: a bivariate meta-analysis.
    Chiang WN; Huang PY; Kuo HC; Huang YH; Chang LS
    Front Cardiovasc Med; 2023; 10():1164530. PubMed ID: 37378410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of blood inflammatory markers for predicting intravenous immunoglobulin resistance in Kawasaki disease: A systematic review and meta-analysis.
    Liu C; Wu J
    Front Pediatr; 2022; 10():969502. PubMed ID: 36081627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy between low and high dose aspirin for the initial treatment of Kawasaki disease: Current evidence based on a meta-analysis.
    Zheng X; Yue P; Liu L; Tang C; Ma F; Zhang Y; Wang C; Duan H; Zhou K; Hua Y; Wu G; Li Y
    PLoS One; 2019; 14(5):e0217274. PubMed ID: 31117119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
    Shao S; Zhou K; Liu X; Liu L; Wu M; Deng Y; Duan H; Li Y; Hua Y; Wang C
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e4210-e4220. PubMed ID: 33837779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease.
    Türkuçar S; Yıldız K; Acarı C; Dundar HA; Kır M; Ünsal E
    Turk J Pediatr; 2020; 62(1):1-9. PubMed ID: 32253860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unique Molecular Patterns Uncovered in Kawasaki Disease Patients with Elevated Serum Gamma Glutamyl Transferase Levels: Implications for Intravenous Immunoglobulin Responsiveness.
    Wang Y; Li Z; Hu G; Hao S; Deng X; Huang M; Ren M; Jiang X; Kanegaye JT; Ha KS; Lee J; Li X; Jiang X; Yu Y; Tremoulet AH; Burns JC; Whitin JC; Shin AY; Sylvester KG; McElhinney DB; Cohen HJ; Ling XB;
    PLoS One; 2016; 11(12):e0167434. PubMed ID: 28002448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Procalcitonin as a Biomarker of Unresponsiveness to Intravenous Immunoglobulin for Kawasaki Disease.
    Nakamura N; Muto T; Masuda Y; Numoto S; Kodama S; Miyamoto R; Miyata K; Hayakawa T; Mori H; Kuroyanagi Y; Akaihata M; Iwayama H; Kurahashi H; Shimomura Y; Nagai T; Hori T; Agata H; Okumura A
    Pediatr Infect Dis J; 2020 Sep; 39(9):857-861. PubMed ID: 32433223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nomogram to predict risk of resistance to intravenous immunoglobulin in children hospitalized with Kawasaki disease in Eastern China.
    Huang H; Jiang J; Shi X; Qin J; Dong J; Xu L; Huang C; Liu Y; Zheng Y; Hou M; Shen Q; Zeng B; Qian G; Yang F; Lv H
    Ann Med; 2022 Dec; 54(1):442-453. PubMed ID: 35099338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indirect-comparison meta-analysis of treatment options for patients with refractory Kawasaki disease.
    Chan H; Chi H; You H; Wang M; Zhang G; Yang H; Li Q
    BMC Pediatr; 2019 May; 19(1):158. PubMed ID: 31101091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease.
    Li W; Zhang L; Wang Z; He X; Lin H; Wang Y; Yuan J; Xie X; Zhang X; Qin Y; Huang P
    Int J Clin Pract; 2022; 2022():2726686. PubMed ID: 35989868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Xie T; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
    Pediatr Rheumatol Online J; 2017 Mar; 15(1):17. PubMed ID: 28320400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in Peripheral Blood Neutrophils, Lymphocytes and IL-10 in Children with Kawasaki Disease from Different Age Groups Undergoing Intravenous Immunoglobulin: A Retrospective Study.
    Zhang C; Zhang X; Shen J; Lu X; Zhang J; Chen S
    Mediators Inflamm; 2020; 2020():5213451. PubMed ID: 33293897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indicators of unresponsiveness after initial i.v. immunoglobulin treatment in acute Kawasaki disease.
    Hashimoto I
    Pediatr Int; 2019 Jul; 61(7):641-646. PubMed ID: 31132210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.